Rise of Bio-based Chemicals: Hype or Game-Changer?: Dr. Sangeeta Srivastava, Executive Director, Godavari Biorefineries
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
The Protect VL project was born out of a vision to reduce the environmental footprint of medical devices
The change of name has been carried on pursuant to the Scheme of Amalgamation
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
Bayer expects 2025 to be the most difficult year of its turnaround
Subscribe To Our Newsletter & Stay Updated